Literature DB >> 10838608

Nicotinic receptor function: new perspectives from knockout mice.

M Cordero-Erausquin1, L M Marubio, R Klink, J P Changeux.   

Abstract

Knockout mice, in which one or more genes of interest are silenced, provide unique opportunities to analyse diverse aspects of gene function in vivo. In particular, the contribution of the encoded protein(s) in complex behaviours can be assessed. Since the first targeted disruption in 1995 of the gene encoding the beta2-subunit of the nicotinic acetylcholine receptor (nAChR), all but a few of the mammalian nAChR subunits have been disrupted (i.e. alpha7, alpha4, alpha3, alpha9, beta4 and beta3). Recent advances brought by genetically modified mice to our understanding of the endogenous composition and role of nAChRs in the nervous system, and of the diverse pharmacological actions of nicotine regarding learning, analgesia, reinforcement, development and aging in the brain will be discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10838608     DOI: 10.1016/s0165-6147(00)01489-9

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  83 in total

1.  Neuroscience from different angles. Student symposium: from genes to thoughts.

Authors:  T Schell; G Testa; S Castagnetti; B Rutz; M Hannus; F Frischknecht
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

2.  Requirement of the nicotinic acetylcholine receptor beta 2 subunit for the anatomical and functional development of the visual system.

Authors:  F M Rossi; T Pizzorusso; V Porciatti; L M Marubio; L Maffei; J P Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

3.  Involvement of aryl hydrocarbon receptor nuclear translocator in EGF-induced c-Jun/Sp1-mediated gene expression.

Authors:  Wan-Chen Huang; Shu-Ting Chen; Wei-Chiao Chang; Kwang-Yu Chang; Wen-Chang Chang; Ben-Kuen Chen
Journal:  Cell Mol Life Sci       Date:  2010-05-28       Impact factor: 9.261

4.  Differential α4(+)/(-)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms.

Authors:  Linda M Lucero; Maegan M Weltzin; J Brek Eaton; John F Cooper; Jon M Lindstrom; Ronald J Lukas; Paul Whiteaker
Journal:  J Biol Chem       Date:  2015-12-07       Impact factor: 5.157

5.  Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.

Authors:  Astrid K Stoker; Berend Olivier; Athina Markou
Journal:  Behav Genet       Date:  2011-10-19       Impact factor: 2.805

Review 6.  Nicotinic modulation of hippocampal cell signaling and associated effects on learning and memory.

Authors:  Munir Gunes Kutlu; Thomas J Gould
Journal:  Physiol Behav       Date:  2015-12-11

7.  Requirement of nicotinic acetylcholine receptor subunit beta2 in the maintenance of spiral ganglion neurons during aging.

Authors:  Jianxin Bao; Debin Lei; Yafei Du; Kevin K Ohlemiller; Arthur L Beaudet; Lorna W Role
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

Review 8.  Nicotinic modulation of neuronal networks: from receptors to cognition.

Authors:  Huibert D Mansvelder; Karlijn I van Aerde; Jonathan J Couey; Arjen B Brussaard
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

9.  Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.

Authors:  Sheela K Chellappan; Yingxian Xiao; Werner Tueckmantel; Kenneth J Kellar; Alan P Kozikowski
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

Review 10.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.